Total Payments
$4,013
2024 Payments
$1,203
Companies
38
Transactions
138
Medicare Patients
5,166
Medicare Billing
$243,487
Payment Breakdown by Category
Food & Beverage$4,013 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,013 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $566.47 | 8 | $0 (2020) |
| ABBVIE INC. | $552.55 | 24 | $0 (2024) |
| Amgen Inc. | $506.47 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $476.89 | 7 | $0 (2024) |
| Novo Nordisk Inc | $264.93 | 11 | $0 (2024) |
| PFIZER INC. | $242.59 | 11 | $0 (2024) |
| Exact Sciences Corporation | $200.63 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $148.70 | 3 | $0 (2024) |
| Boston Scientific Corporation | $145.35 | 4 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $119.30 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,203 | 37 | Amgen Inc. ($345.18) |
| 2023 | $723.79 | 25 | AbbVie Inc. ($143.64) |
| 2022 | $433.01 | 17 | AstraZeneca Pharmaceuticals LP ($94.42) |
| 2021 | $224.30 | 15 | AbbVie Inc. ($94.22) |
| 2020 | $161.51 | 7 | E.R. Squibb & Sons, L.L.C. ($77.24) |
| 2019 | $504.48 | 21 | E.R. Squibb & Sons, L.L.C. ($184.32) |
| 2018 | $474.03 | 7 | E.R. Squibb & Sons, L.L.C. ($223.61) |
| 2017 | $289.07 | 9 | PFIZER INC. ($118.59) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/10/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $89.62 | General |
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.19 | General |
| 10/20/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $143.76 | General |
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Bone Health | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: VACCINE | ||||||
| 08/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Inflammation | ||||||
| 07/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Endocrinology | ||||||
| 05/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Inflammation | ||||||
| 05/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.58 | General |
| 05/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $107.41 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Biological | ||||||
| 03/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.30 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,005 | 1,796 | $296,325 | $70,233 |
| 2022 | 13 | 798 | 1,007 | $175,621 | $43,143 |
| 2021 | 13 | 1,652 | 2,034 | $170,428 | $72,109 |
| 2020 | 15 | 1,711 | 2,121 | $143,163 | $58,003 |
Total Patients
5,166
Total Services
6,958
Medicare Billing
$243,487
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 391 | $70,380 | $16,379 | 23.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 94 | 375 | $69,375 | $13,107 | 18.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 90 | 273 | $30,030 | $9,720 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 191 | $25,785 | $7,327 | 28.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 76 | 77 | $8,470 | $5,535 | 65.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $9,450 | $5,082 | 53.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 42 | 133 | $11,970 | $3,970 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 80 | 81 | $3,078 | $2,317 | 75.3% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 14 | 14 | $4,046 | $1,799 | 44.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,510 | $1,571 | 44.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 163 | 163 | $44,825 | $1,078 | 2.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 18 | $8,370 | $859.80 | 10.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $1,260 | $533.68 | 42.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $646.00 | $486.20 | 75.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $5,130 | $467.02 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 339 | $59,935 | $13,580 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 212 | $27,484 | $8,536 | 31.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 28 | 28 | $14,548 | $7,808 | 53.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 65 | 66 | $7,260 | $4,517 | 62.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 69 | $2,622 | $1,861 | 71.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $3,510 | $1,786 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 163 | 163 | $44,216 | $1,123 | 2.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 16 | $7,200 | $1,117 | 15.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 32 | 32 | $1,216 | $866.52 | 71.3% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 17 | 17 | $1,530 | $611.42 | 40.0% |
About Dr. Barry Wendt, MD
Dr. Barry Wendt, MD is a Specialist healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801888177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Wendt, MD has received a total of $4,013 in payments from pharmaceutical and medical device companies, with $1,203 received in 2024. These payments were reported across 138 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,013).
As a Medicare-enrolled provider, Wendt has provided services to 5,166 Medicare beneficiaries, totaling 6,958 services with total Medicare billing of $243,487. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine, Internal Medicine
- Location Crestview Hills, KY
- Active Since 08/22/2005
- Last Updated 08/19/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1801888177
Products in Payments
- ELIQUIS (Drug) $736.04
- VRAYLAR (Drug) $335.46
- BREZTRI (Drug) $232.40
- Otezla (Drug) $200.61
- Ozempic (Drug) $159.17
- WATCHMAN (Device) $145.35
- Veozah (Drug) $136.78
- QULIPTA (Drug) $133.07
- Cologuard Collection Kit (Device) $129.32
- AIRSUPRA (Drug) $126.63
- JARDIANCE (Drug) $119.30
- FARXIGA (Drug) $117.86
- LEQVIO (Drug) $80.79
- UBRELVY (Drug) $59.02
- XIFAXAN (Drug) $53.39
- Saxenda (Drug) $52.44
- Creon (Drug) $40.84
- XARELTO (Drug) $39.23
- VYVANSE (Drug) $38.86
- Repatha (Biological) $34.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Crestview Hills
Dr. Kara Shay, Md, MD
Specialist — Payments: $2,418
Specialist $2,418
Dr. Glen Turner, Md, MD
Specialist — Payments: $943.99
Specialist $943.99
Mark Meier, Md, MD
Specialist — Payments: $602.94
Specialist $602.94
Del Burchell, Md, MD
Specialist — Payments: $596.12
Specialist $596.12
Terry Mcdannold, Md, MD
Specialist — Payments: $338.65
Specialist $338.65
Dr. T Sommerkamp, M.d, M.D
Specialist
Specialist